首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.
【2h】

Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

机译:从痤疮患者中分离出的皮肤丙酸杆菌中对红霉素和克林霉素的临床耐药性与23S rRNA突变有关。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The genetic basis of erythromycin resistance in cutaneous propionibacteria was determined by comparing the nucleotide sequences of the peptidyl transferase region in the 23S rRNAs from 9 susceptible and 26 resistant clinical isolates as well as 4 laboratory-selected erythromycin-resistant mutants of a susceptible strain. In 13 isolates and the 4 laboratory mutants, cross-resistance to macrolides, lincosamides, and B-type streptogramins was associated with an A-->G transition at a position cognate with Escherichia coli 23S rRNA base 2058. These strains were resistant to > or = 512 microg of erythromycin per ml. Two other mutations were identified, an A-->G transition at base 2059 in seven strains, associated with high-level resistance to all macrolides, and a G-->A transition at base 2057 in six strains, associated with low-level resistance to erythromycin. These mutations correspond to three of four phenotypic classes previously identified by using MIC determinations.
机译:通过比较来自9个易感和26个耐药临床分离株以及4个实验室选择的易感菌株的红霉素突变体的23S rRNA中肽基转移酶区域的核苷酸序列,确定了皮肤丙酸杆菌中红霉素抗性的遗传基础。在13个分离株和4个实验室突变株中,对大环内酯类,林可酰胺和B型链霉菌素的交叉耐药性与大肠杆菌23S rRNA碱基2058同源的A-> G过渡相关。这些菌株对>或=每毫升512微克红霉素。鉴定出另外两个突变,七个菌株在2059碱基的A-> G过渡,与所有大环内酯类药物的高水平抗性相关;六个菌株在2057碱基的G-> A过渡,与低水平相关。对红霉素有抗药性。这些突变对应于先前使用MIC测定确定的四个表型类别中的三个。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号